Executive Summary: North America Oxygen Therapy Market

Market Scope: North American oxygen therapy market analysis covering product types (source and delivery equipment), clinical applications, end-user care settings (home healthcare vs. hospitals), and country-level dynamics.
Market Valuation: Valued at USD 1.16 billion (2025), estimated at USD 1.22 billion (2026), and projected to reach USD 1.87 billion by 2034, expanding at a steady CAGR of 5.51% (2026–2034).
Primary Growth Drivers: Escalating prevalence of chronic respiratory disorders (COPD, asthma, obstructive sleep apnea), rising geriatric population and smoking demographics, and rapid technological advancements (portable oxygen concentrators, pulse oximeters, and lightweight battery systems). Key restraints include convoluted reimbursement processes, high device costs, and geopolitical trade uncertainties impacting supply chains.

Key Market Segment Metrics (2026–2034)

Category	Leading Segment / Position	Growth Trajectory & Details (2026–2034)
By Product Type	Oxygen Source Equipment (Concentrators & Cylinders)	Stationary and portable oxygen concentrators lead source devices, while oxygen delivery devices encompass nasal cannulas, standard masks, venturi models, and non-rebreathers.
By Application	Chronic Obstructive Pulmonary Disease (COPD)	Represents the largest indication share. Other notable application verticals include asthma, obstructive sleep apnea (OSA), respiratory distress syndrome, cystic fibrosis, and pneumonia.
By End-User	Home Healthcare	Demonstrates high adoption as patients prefer decentralized, long-term ambulatory care. Hospitals maintain a critical secondary share for acute interventions.
By Country	The United States (Dominant market leader)	Driven by a massive healthcare expenditure capacity, high prevalence of COPD/OSA, and sophisticated medical infrastructure. Canada follows with solid regional adoption.

Major Market Players & Market Structure

Market Structure: Moderately consolidated and regulated market featuring prominent medical device manufacturers focusing on R&D, patient mobility enhancements, and digital health integrations for the 2026–2034 forecast period.

Key Companies: Chart Industries Inc., Invacare Corporation, Becton, Dickinson and Company, Smiths Medical, Teleflex Incorporated, Inogen, DeVilbiss Healthcare, Essex Industries, Inc., Allied Healthcare Products Inc., and Respan Products Inc.

North America Oxygen Therapy Market Size

The North America Contact Lenses Market size was valued at USD 1.16 billion in 2025. The size of the Oxygen Therapy Market in North America is estimated to grow from USD 1.22 billion in 2026 to USD 1.87 billion by 2034, growing at a CAGR of 5.51% during the forecast period.

Oxygen therapy involves administering oxygen through an external device.

The oxygen therapy equipment is used to treat various illnesses, including chronic obstructive pulmonary disease, asthma, and other respiratory conditions. The market for oxygen therapy in North America is expanding due to the rising frequency of various respiratory disorders. In addition, the rising demand for technologically sophisticated systems, such as portable oxygen concentrator systems, has also aided the expansion of the oxygen therapy market. Pulse oximeter devices and nasopharyngeal oxygen therapy are two key advancements. The market for these goods is increasing due to several causes, such as technological advancements and increased awareness within the medical community about the development of solutions for early treatment. Additionally, shifting government attempts to increase the availability and access to medical resources in rural places results in people seeking respiratory treatment earlier.

Due to reasons such as an increase in the number of smokers in the population, an increase in the number of patients suffering from respiratory illnesses, and more, North America is expected to have the biggest share of the oxygen therapy equipment market in the future years. Furthermore, in the next few years, increased collaboration between manufacturers and healthcare providers will likely boost demand for improved oxygen therapy products. In addition, increased research and development activities in the field of respiratory health by different medical and biomedical firms and growth in illness indications such as COPD and asthma in North America are projected to enhance the oxygen therapy market. This has increased demand for oxygen cylinders and other equipment, which is expected to propel market expansion in the future years.

Growing geopolitical issues impacting medical product commerce, uncertainties, and cases of health indicator misinformation and rising civil unrest are expected to cause problems on the effective balance of product demand and supply. In addition, the convoluted reimbursement process has also restricted the expansion of the North America Oxygen therapy market.

Due to many strict regulatory rules, the oxygen therapy industry is projected to retain a small number of competitors, posing a moderate threat to the market. Furthermore, the cost restrictions connected with oxygen therapy equipment are expected to influence demand negatively.

REGIONAL ANALYSIS

Geographically, the U.S. is expected to lead the regional market due to rising COPD instances among its citizens. In addition, technological advances and high awareness about the availability of treatment for several chronic respiratory diseases are expected to drive the market in the coming years. Due to a rise in the number of product approvals, rising need for oxygen filling devices, an aging population, an increased number of untreated sleep apnea cases, and high R&D investment, North America is expected to lead the global Oxygen Therapy market. The region's growth may be linked to increased government and private expenditures in healthcare to maintain the highest level of treatment available in healthcare facilities. Compared to many other nations, the US healthcare infrastructure is extremely sophisticated, with high availability of medical technology and state-of-the-art facilities and the largest spending capacity in the healthcare sector of any country in the world.

KEY MARKET PLAYERS

A few of the prominent companies operating in the North American Oxygen Therapy Market include

Chart Industries Inc.
Invacare Corporation
Becton, Dickinson and Company
Smiths Medical
Teleflex Incorporated
Inogen
DeVilbiss Healthcare
Essex Industries, Inc.
Allied Healthcare Products Inc.
Respan Products Inc.

MARKET SEGMENTATION

This research report on the North American Oxygen Therapy Market has been segmented & sub-segmented into the following categories.

By Product Type

Oxygen Source Equipment
- Oxygen Concentrators
  - Fixed Oxygen Concentrators
  - Portable Oxygen Concentrators
- Liquid Oxygen Devices
- Oxygen Cylinders
Oxygen Delivery Devices
- Oxygen Masks
- Nasal Cannulas
- Venturi Masks
- Non-Rebreather Masks
- Bag Valve Masks
- Other Devices

By Application

Chronic Obstructive Pulmonary Disease
Asthma
Obstructive Sleep Apnea
Respiratory Distress Syndrome
Cystic Fibrosis
Pneumonia

By End-user

Home Healthcare
Hospitals

By Country

The United States
Canada
Rest of North America

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

North America Oxygen Therapy Market Report